RxDoctor Payments Data

Erich Slocum, DO

Family Medicine · Rantoul, ILNPI 1356625362

Payments from drug & device makers

$4,051in general payments, 2019–2025

Across 223 payments — averaging $18.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Johnson & Johnson$381
  • Pfizer$349
  • Novo Nordisk$276
  • Amgen$265
  • Novartis$259
  • plus $2K from 18 others

What the payments were for

  • Food & beverage$4,042100%
  • Education$90%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,051 in reported general payments places this provider in the 85th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$51,974
Medicare patients
191
Services billed
677

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide118$116,779
EliquisApixaban124$110,803
JardianceEmpagliflozin67$82,002
TradjentaLinagliptin52$57,387
XareltoRivaroxaban43$39,677
Trelegy ElliptaFluticasone/Umeclidin/Vilanter41$30,406
MounjaroTirzepatide26$27,311
Breztri AerosphereBudesonide/Glycopyr/Formoterol45$26,735
JanuviaSitagliptin Phosphate25$21,404
Albuterol Sulfate HfaAlbuterol Sulfate220$12,312
Gabapentin230$6,139
Breo ElliptaFluticasone/Vilanterol13$5,991
Atorvastatin Calcium367$5,886
DuleraMometasone/Formoterol16$5,316
Pregabalin109$4,598

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$242$139,389119 claims
Novo NordiskOzempic$276$116,779118 claims
PfizerEliquis$349$110,803124 claims
Johnson & JohnsonXarelto$381$39,67743 claims
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta$207$39,56266 claims
AstraZenecaBreztri Aerosphere, Symbicort$1,008$31,31661 claims
Lilly USA, LLCMounjaro$214$27,31126 claims
MerckJanuvia, Dulera$14$26,72041 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Rantoul

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →